A Randomized, Multicenter Comparison of the NEVO Sirolimus-Eluting Coronary Stent With the TAXUS Liberté Paclitaxel-Eluting Stent in De Novo Native Coronary Artery Lesions

John A. Ormiston, MBChB; Alexandre Abizaid, MD, PhD; John Spertus, MD, PhD; Jean Fajadet, MD; Laura Mauri, MD, MPH; Joachim Schofer, MD, PhD; Stefan Verheye, MD, PhD; Joseph Dens, MD, PhD; Leif Thuesen, MD; Christophe Dubois, MD, PhD; Rainer Hoffmann, MD; William Wijns, MD, PhD; Peter J. Fitzgerald, MD, PhD; Jeffrey J. Popma, MD, PhD; Nathalie Macours, PhD; Ana Cebrian, PhD; Hans-Peter Stoll, MD; Campbell Rogers, MD; Christian Spaulding, MD, PhD; on behalf of the NEVO ResElution-I Investigators